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SUMMARY
The prevalence of myasthenia gravis is low. The management implications of this 
disease in pregnant women are very challenging for anaesthetists. The objective is 
to highlight some of the challenges, the management and the lessons learnt during 
the management of this patient. This is a case report of a 31-year old parturient with 
diagnosed myasthenia gravis co-existing with hepatitis B infection that presented 
for caesarean section. Surgery was carried out under a single-shot spinal anaesthesia 
with bupivacaine. Intraoperative myasthenia crisis was managed with neostigmine 
infusion. She was managed in the Intensive Care Unit for a few days and discharged. 
Under spinal anaesthesia, she became very breathless and developed wide-spread 
musculo-skeletal weakness while having a stable haemodynamics intra-operatively. 
Surgery was carried out successfully. Both mother and child were discharged on the 
7th day post-operative after baby was confirmed sero-negative of hepatitis B surface 
antigen. A better understanding of the pathophysiology and complications that 
accompany myasthenia gravis is needed to manage these patients under anaesthesia.
INTRODUCTION
Myasthenia gravis (MG) is an acquired, 
neuromuscular, autoimmune disease that presents 
clinically with weakness and fatigue of the skeletal 
muscles. The disorder is characterised by a decrease 
in the number of acetylcholine receptorsin the 
neuromuscular plates, due to an autoimmune process 
mediated by antibodies directed against the alpha-
subunit of the nicotine receptor of the acetylcholine (1). 
The prevalence of the disease in Nigeria is not known 
but world-wide, it is twice as common in women as 
in men and frequently affects young women in the 
second and third decades of life, overlapping with 
the childbearing years (2, 3). 
 During pregnancy the course of this disease is 
unpredictable; but worsening of symptoms occurs 
more likely during the first half of pregnancy and 
postpartum. In one third of patients the disease 
exacerbates, whereas in two thirds it remains 
clinically unchanged (4, 5). Although myasthenia 
gravis constitutes a high risk, it can be well managed 
during pregnancy with relatively safe and effective 
therapies. 
We report the management of a Hepatitis B 
seropositive patient with myasthenia gravis 
scheduled for Caesarean section due to prolonged 
rupture of membrane (PROM) and cephalopelvic 
disproportion (CPD).
CASE REPORT
A 31-year old Gravida 2 Para 1 registered patient 
presented to the labour ward of the University of 
Port Harcourt Teaching Hospital, Port Harcourt with 
a four-hour history of labour pains. She was a known 
patient with myasthenia gravis diagnosed about 
five years ago and was placed on treatment with 
mestinon (Pyridostigmine 30 mg) and prednisolone 
2.5 mg daily. Following this medical treatment she 
had significant remission of the disease with occasional 
periods of exacerbation. Pre-natal history suggested 
that she had occasional episodes of cholinergic crisis.
The last episode was about six months prior to the 
registration of this pregnancy. Her past obstetrical 
history included a Caesarean section due to CPD – of 
a 3800 g MG asymptomatic alive female child. 
 During the antenatal booking, her indices were; 
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height 167 cm, weight 119 kg (BMI 42.7), blood pressure 
was 120/80 mmHg. Following routine laboratory 
investigation during this pregnancy, she was found 
to be Hepatitis B surface antigen sero-positive, blood 
group B rhesus D positive, haemoglobin genotype 
AA, packed cell volume - 33%. She was however 
sero-negative for HIV and syphilis. Although the 
antenatal period was uneventful, her attendance to 
both Antenatal and Medical Outpatient Clinics were 
not regular. A repeat ultrasound examination at 36th 
week gestation showed a normal and well developed 
foetus. The amniotic fluid and foetal movements were 
also normal.
 On presentation at the labour ward, general 
examination revealed that she was in painful distress 
and had mild pallor with mild to moderate respiratory 
distress as evidenced by a flaring alae nasi and heavy 
breathing. A vaginal examination showed that the 
cervical os was five centimetres dilated with 40 percent 
effacement. She had had a spontaneous rupture of 
the membrane about six hours before presentation. 
The cardiovascular system was essentially normal 
but the central nervous system examination showed 
mild bilateral ptosis, and generalised hypotonia with 
weakness of the intercostal muscles. The patient’s 
functional status was classified according to the 
Osserman (6) Grade n. She could not force-open her 
mouth against moderate resistance. The foetal heart 
rate was 144 beats per minute strong and regular. 
On the American Society of Anaesthesiologists 
(ASA) physical status classification she was assessed 
to be Class III (Emergency). Following the mild 
to moderate central nervous system affectation, 
respiratory difficulty, premature rupture of membrane 
and cephalopelvic disproportion, a decision for an 
emergency Caesarean section was made. Consent for 
surgery was obtained from and mode of anaesthesia 
also explained to the patient. 
 The Caesarean delivery was performed under 
spinal anaesthesia. Standard monitors measuring 
noninvasive blood pressure (NIBP), electro-
cardiogram (ECG), and peripheral oxygen saturation 
(SPO2) were used on this patient. We opted to initiate 
neuraxial anaesthesia with supportive non-invasive 
ventilation in the peri-operative period, although 
we were fully prepared for tracheal intubation and 
full ventilator support should her respiratory status 
deteriorate. For the induction of spinal anaesthesia, 
she was positioned sitting with the feet resting on 
a stool. While observing asepsis, and using the 
L3/4 Intervertebral space, the subarachnoid space 
was located after a single pass with an extralong 
(115 mm) 25-gauge Quincke spinal needle. Spinal 
anaesthesia was induced with 0.5% bupivacaine 
plain 10 mg. She was returned to the supine position 
while ensuring left lateral uterine displacement and 
10 degree head-up tilt. Diclofenac suppository 200 
mg was inserted before skin incision was made. A 
maximum T5/T6 sensory level was reached after six 
minutes. Supplemental oxygen at flow rate of 6 l/min 
was administered to her via a face mask. She had a 
significant relief in respiratory function following an 
infusion of neostigmine 5 mg in 100 ml normal saline 
over 10 minutes and intravenous hydrocortisone 200 
mg.
 Following a Pfannenstiel skin incision with low 
transverse uterine incision, a female infant weighing 
4200 g was delivered with a placental weight of 600 g. 
The Apgar scores of the baby were seven and nine at 
one and five minutes, respectively. The intra-operative 
cardiovascular parameters were stable. The baby was 
immediately admitted into the Special Care Baby Unit 
(SCBU) for assessment and observation, but there 
were no symptoms of neonatal MG observed. Post-
operative pain management in the mother was with 
diclofenac suppository 200 mg 12 hourly and titrable 
doses of pentazocine (a benzomorphan derivative) 
30-45 mg four to six hourly for 48 hours. She had a 
satisfactory pain relief.
 Although the mother was also admitted 
into Intensive Care Unit (ICU) of the hospital for 
monitoring, she was able to commence breast-feeding 
immediately. However, following an exacerbation 
of muscle weakness and fatigability in the ICU, a 
further neostigmine 5 mg in 100 ml normal saline 
every six hours and supplemental oxygen 61/min by 
nasal prongs. She also received daily intramuscular 
hydrocortisone 200 mg was administered until she 
resumed oral feeding on the second post-operative 
day. She was however discharged from the ICU 
on the third day post-operative into the postnatal 
unit of the hospital. The subsequent post-operative 
course was uneventful and, both mother and child 
were discharged home from the hospital on the 7th 
post-operative day. The postnatal period was also 
uneventful for the mother and child.
DISCUSSION
The course of MG in pregnancy, as well as its 
influence on outcome is unpredictable. This could 
be made worse when there is a combination of poor 
patient compliance to both drug treatment and clinic 
followup. The high-risk patient in this report was 
diagnosed with MG but did not have a consistent 
antenatal and medical follow-up. This could account 
for her relatively frequent periods of exacerbations.
 Myasthenia gravis co-existing with pregnancy is 
not common in Nigeria but world-wide it occurs in 
1:20, 000 - 40, 000 pregnancies (2, 3, 7). This explains 
why the anaesthetic management of these patients 
could be a challenge when they present for surgery. 
 The ideal anaesthetic technique for high risk 
patients with myasthenia gravis is not known. The 
main challenges faced in our patient were essentially 
those of muscle weakness she presented with, the 
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peri-operative use of anticholinestrase and the need to 
achieve a relaxation of the surgical field. To overcome 
these challenges, the technique of regional anaesthesia 
was used. The use of this technique of anaesthesia 
has also been recommended (8). The advantages 
of regional anaesthesia include avoidance of 
intravenous opioids, neuromuscular blocking drugs, 
and anticholinesterases. The use of neuromuscular 
blocking agents and the tendency of anticholinestrase 
overdose itself may cause considerable and excessive 
muscle weakness.
 General anaesthesia with tracheal intubation will 
be more appropriate if there is bulbar involvement, 
or severe respiratory compromise is present. In such 
circumstances, the principles guiding anaesthetic 
management of patients with MG are the use of 
shortacting opioids, muscle relaxants, and inhaled 
anaesthetics: all being agents with rapid recovery 
profile. Due to acetylcholine receptor down 
regulation, these patients are very sensitive to 
non-depolarising muscle relaxants and potentially 
resistant to depolarising muscle relaxants. However, 
general anaesthesia with tracheal intubation ensures 
adequacy of ventilation and also confers airway 
protection from gastric soilage.
 We had to use neuraxial anaesthesia with 
oxygen support by face mask in the perioperative 
period, although we were fully prepared for tracheal 
intubation and full ventilatory support in the event 
of deteriorating respiratory status. 
 Although we decided to use a single-shot spinal 
technique, the use of continuous spinal or epidural 
anaesthesia technique with catheter and combined 
spinal-epidural anaesthesia have been suggested (9, 
10), as they allow titration of the local anaesthetic 
dose. Continuous spinal anaesthesia would have 
required dural puncture with an epidural needle, 
and the consequent increased risk of post-dural 
puncture headache (10). The advantage of spinal 
anaesthesia over epidural anaesthesia as previously 
recommended8 requires the use of a smaller dose 
of local anaesthetic. It has been demonstrated that 
large doses of local anaesthetic infused epidurally 
interferes with neuromuscular transmission (11). 
The subarachnoid dose of the bupivacaine used in 
our patient was adequate. There was satisfactory 
anaesthesia and adequate surgical relaxation without 
any adverse effects.
 Intra-operative neostigmine 5 mg in 100 ml 
normal saline was administered when a 1 mg could 
not improve the respiratory difficulty experienced 
intra-operatively. Although it has been shown that 
an equivalent dose of intravenous pyridostigmine 
4 mg can be used to replace oral doses of 120 mg, 
and intravenous neostigmine 1 mg replacing oral 
doses of 30 mg (12), our patient needed up to 5 mg 
of neostigmine in 100 ml normal saline administered 
over 10-20 minutes before the respiratory insufficiency 
from muscle weakness could be effectively treated. 
The management of MG patients in the ICU can 
also pose some challenges especially following 
thymectomy. The use of standard protocols for 
the management of these patients would produce 
better results in terms of the number of cholinergic 
and myasthenic crises, and duration of respiratory 
support. Our patient did not require full ventilator 
support as evidenced by her ability to care for her 
baby with minimal support. 
 Babies of mothers suffering from MG mayor may 
not display symptoms at birth. The baby delivered 
by our patient did not show any symptoms of MG. 
The baby was put to the breast almost immediately 
after birth. Unlike pyridostigmine, neostigmine is 
not excreted into the breast milk (14, 15). Although 
neostigmine is ionised at physiologic pH; the low 
molecular weight (about 223) is low enough for the 
non-ionised fraction to be excreted into milk. The 
effects, if any, on a nursing infant from exposure to 
neostigmine in milk is however unknown. 
 A subtle but more hazardous challenge in our 
patient was that she was hepatitis B surface antigen 
sero-positive. Mother-to-child transmission (MTCT) 
of hepatitis B virus (HBV) is one of the most important 
causes of chronic HBV infection (16,17,18). It remains 
one serious problem despite passive immunisation 
(hepatitis B immune globulin at birth) and active 
immunisation (hepatitis B vaccination according 
to the standard 3-dose schedule). MTCT may occur 
prenatally, during delivery, or postpartum. 
 Currently, a series of measures have been taken 
to prevent both prenatal and postpartum routes of 
transmission with progress being achieved to some 
extent. However, with regard to MTCT of HBV 
during delivery, disagreements still exist on the issue 
of whether a different mode of delivery (mainly 
caesarean section versus vaginal delivery) will affect 
the risk of mother- to-child HBV transmission (19, 
20).
 Of the cases of MTCT of HBV, a large proportion 
occurs during the intrapartum period. Underlying 
mechanisms may include transfusion of the mother’s 
blood to the foetus during labour contractions, 
infection after the rupture of membranes, and direct 
contact of the foetus with infected secretions or blood 
from the maternal genital tract (21, 22). As elective 
caesarean section (ECS) is performed before the 
onset of labour or the rupture of membranes, it could 
effectively avoid the disadvantages described above.
Therefore, ECS might reduce the risk of MTCT of HBV 
(compared with vaginal delivery, Caesarean section 
after onset of labour or after rupture of membranes). 
However this was not the case for our patient. 
She presented in established labour, had ruptured 
membranes and eventually an emergency Caesarean 
section was done. A serology test for hepatitis B surface 
antigen carried out on the baby was negative and the 
neonate was subsequently immunised.
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In conclusion, the management of a high risk patient 
with myasthenia gravis can be very challenging. 
This is worse in the presence of bulbar involvement 
or respiratory insufficiency. Myasthenia gravis can 
be successfully managed during pregnancy with a 
combination of pharmaceutical agents with good 
maternal and foetal outcome. Our patient had a 
significant measure of respiratory challenge which 
was successfully managed and she was discharged 
from the hospital. The management of such patients 
during pregnancy should be a multidisciplinary 
approach involving neurologists, obstetricians, 
paediatricians, and obstetric anaesthesiologists 
during pregnancy and delivery.
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